Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001493152-26-042754

CEO & President bought 5,900 shares at $0.22 ($1,292)

From the SEC's structured data for this filing

Trades in this filing

Equels Thomas K · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-14 Purchase : show line 1 in the form +5,900 $0.22 $1,292 69,822 D
Open-market purchases · 5,900 sh · avg $0.22 · $1,292
Loading xslF345X06/ownership.xml…